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Abstract 
A serious problem using liposomes for therapeutic purposes is the tk=st removal front blood circulation by cnmponenls of 
the reticuloendothelial system (RES) most likely after opsonization of the vesicles. This study was perlbrmed to quantify the 
reduction in reaerophage uptake in vitro of stefically stabilized lipost)mes (PEG-liposomes) prepared from hexadecylphos- 
phocholine, cholesterol and poly(ethylene glycol~n~j(~) distearoylphosphoethanolamine (PEG,0~mDSPE) for the first time. The 
uptake was determined using HPC-liposomes of different defined size (125, 250 and 10IN) nm) withou! and with sterieal 
stabilization by incorporating 5 tool% of PEG=q~0oDSPE. HPTS was used as fluorescence marker allowing the discrimination 
between general uptake and the part of liposomes internalized into the low pH compartment (Daleke, L.D.. Hung. K. and 
Papahadjopoulos, D. (1990) Biochim. Biophys. Acta 1024. 352-366). Liposomal uptake by J774 mouse macrophage-like 
eell~ was time-dependent. Both the uptake and internalization were clearly reduced tbr PEG-liposomes compared to plain 
liposomes. Sterieal stabilization reduced the generul uptake of liposomes in vitro by more than 50% and the internalization 
by about 50-60%. PEG-liposomes additionally showed a delay in internalization i to the macrophages during the first 6 h. 
Size of used liposomes had only a minor influence on liposomal uptake but highest concentration of lipid was found for 
large multitammelar vesicles (MLV). The fired aqueous layer thickness (FALT) was determined by zeta potential 
measurements of plain and sterically stabilised HPC-liposomes (1130 nm) in solutions of different inn concentrations. The 
calculation of the thickness was based on the linear correlation between In ~" (zeta-potential) and .x (Dehye HEekeI-Parame- 
ted. FALT was calculated and found to be for plain HPC-liposomes 0.83 _+ 0.17 nm and for PEG-HPC-liposomes 
3.57 +0.17 nm. Exchange of the HPC by an alkylphospholipid with different head group has no or only minor effect 
(PEG-OPP-liposomes 3.44 + 0.31 nm). Thus the reduced uptake of HPC-LUVET correlates with an increased thickness of 
Abbreviations: APL. alkylphospholipids: CH. cholesterol: DCP. dicetylphosphate: DSPE, clistearoylglycerophosphuethanulamine; 
DMG, dimyristoylglycerul; DMPC, dimyristoylphosphaUdylchoUnc; DMPG. dimyrismylphosphatidylglyeerol; FALT, fixed aqueous layer 
thickness; FCS. heat-inactivated f tal calf serum; HPC, hexadecylphosphoehuline; HPTS. 8-amino-naphthalene-l.2.3-trisultbnale; LU- 
VET. large unilamellar vesicles by extrusion lechnique: MLV. muhilameilar vesicles: MPS. monocyte phagocytic system: NO. nilroxide; 
OPP, octadecyl (I,l'-dimethyl-piperidino-4-yl)phosphate; PBS, phosphate-buffered saline solution; PC, phosphocholine; PEG, poly(ethyl- 
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the fixed aqueous layer arourtd these liposomes and could support the hypothesis that he thickness i  an important property 
responsible I~}r preventing opsonizatlou and resulting finally in a reduced macrophage uptake. 
h'eu~'ords: Hexadecylph{Tsph¢choline: Macrophage: Phagucytosis: Sterical stabilization: Polylethylene glycol}: Liposome: Mononu¢lear 
phagocytic syslem: Zeta potential: Laree unilamellar vesicle 
I. Introduction 
The use of lip,~somal preparations of anticancer 
drugs offers several advantages in comparison to the 
application of the free drug. Side effects are pre- 
vented and targeting by conjugation of antibodies is 
easily possible. In contrast to classical cancerostatica, 
which are encapsulated into vesicles prepared from 
natural lipids, antineoplastic alkylphospholipids 
(APL) are amphiphilic ompounds with the ability to 
fiJrm stable liposomcs in combination with cholcs- 
terol (CH) and a charged lipid (for example 
dicetylphosphate, DCP) by themselves [1,2], 
The most serious problem in using liposomes is 
that they are quickly removed from blood circulation 
by components of the reticuloendothelial system 
(RES). most likely after opsonizatlon of the vesicles 
[3-51. 
Several attempts have been made to circumvent 
this disadvantage. Besides variation of liposome com- 
position [6-12], size [6.7], amount of cholesterol 
[8,9], surface charge [10], addition of' phos. 
phatidylscrine [7] or gangliosides [10], best results 
have been obtained using sterical stabilization by 
incorporation of phosphoethanolamine derivatives of 
poly(ethylene glycol). These PEG-liposomes (or 
Stealth" liposomes) exhibited an enhanced time of 
cirenhfiiun in vasculatnre [11-14] (for review see 
Refs. [15,16]) and subsequently anincrease was found 
in the drug targeted by liposnmes to tumor tissue 
[17,181. 
First experiments demonstrated that it is possible 
to prepare sterically stabilized HPC-liposomes with- 
out any problems by incorporation of up to 10% 
poly(ethylene glycol) derivatives of phosphatidylser- 
ine [19]. indirect evidence was found for a reduced 
interaction with mouse peritoneal macrophages or 
permanent cell lines comparing the NO- and TNF-re- 
lease l?om cells cuincubated with PEG-lipnsomes or 
with plain liposomes [19.20] in vitro. Additional car- 
bon ink assay in vivo indicated an inhibition of 
immune system respunsc [2(I], 
A great number of data are already available for 
changed biodistribution in vivo [15,16.21]. Several 
experiments have been carried out to investigate the 
influence of different factors on macrophage uptake 
in vitro [6-8,22,23]. On the other hand, only few 
results have been given for a direct comparison of 
PEG- and plain liposome uptake quantified in vitro. 
[241. 
This study was performed tn quantify in vitro the 
macrophage uptake of sterically stabilized liposomes 
prepared from alkylphosphocholines for the first time. 
Several reasons tbr the reduction of macrophage 
uptake are now under discussion. It is most likely that 
either the sterical barrier of hydrophilic chains di- 
rectly or induction of a fixed aqueous layer at the 
liposomal surface indirectly prevents the opsonization 
of the vesicles. 
The fixed aqueous layer thickness can be deter- 
mined by zeta-potential measurements. First results 
using doxorubicine encapsulating Iiposomes prepared 
from DMPC demonstrated a clear difference in the 
thickness of this layer for plain- and PEG-liposomes 
depending on the concentration, ~fthe PEG-lipid [25]. 
FALT was determined for APL for the first time 
and allows the comparison of the biological property 
uptake and the physical property thickness of the 
fixed aqueous layer. 
2. Materials and methods 
2.1. Mater ia ls  
Na-salt ol' N-(O-methy lpo ly (e thy lene  glycol))- 
1,2-dlstearoyl-sn-glyeero-3-pho~phoethanolamine 
(PEG_~(~-DSPE), with about 45 repetitive ethoxy- 
units was purchased from Sygena LTD, Liestal, 
Switzerland. HPC and OPP was a gift from Dr. 
Hilgard (ASTA Medico, Frankfurt. Germany) and 
was stored in a desiccator at room temperature. 
Dicetylphosphate (DCP), cholesterol (CH) and cal- 
cein was purchased from Serva (Heidelberg, Ger- 
many). CH was recrystallized from acetone prior to 
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use. All other chemicals were commercial products of 
reagent grade, 
2.2. Preparation and characterization t~" l iposomes 
Vesicles were prepared flora APL, CH and DCP in 
a molar ratio of 1:1:0.2 ( I ip id/CH/DCP) by the lipid 
layer method as repotted recently [I.20]. For the 
preparation of PEG-liposomes additional PEG-lipid 
(10 mol%) was added as indicated in the tables attd 
figures. The lipid film was hydrated with phosphate- 
buffered saline solution (PBS, pH 7,4) lk~r MLV 
preparation. 
LUVET were prepared by the extrusion tochnique 
according to MacDonald ct al. [26]. Liposomcs tk~r 
uptake experiments were obtained by repeated extru- 
sion (19 times) of 10 mM MLV-suspensions (30 mM 
HPTS)) through polycarbon membranes of 100 nm 
pore size using a LiposoFa .'~ Basic system (Avestin, 
Ottawa, Canada). Liposomes tbr FALT determina- 
tions were produced f~m MLV in lactate butler { 10 
raM, pH 4) by a single extrusion through filter with 
decreasing pore sizes and finally five times through 
filter of 100 nm pore size at 50°C usiug the Ex- 
truder" (aPEX,  Vancouver, Canada). 
HPTS liposomes were separated frnm HPTS by 
centrifugation at 19500 × g (MLV) or by chromatog- 
raphy on Sephadex G75. 
The lipid content and liposomal composition of the 
preparations were checked by high performance 
thin-layer chromatography (Automated Multiple De- 
velopment System and Linomat IV: CAMAG, Mut- 
tenz, Switzerland). 
Vesicle size determination was peribrmed by dy- 
namic light scattering measurement a an angle of 90 
with a Coulter Counter N4 MD model and the Accu- 
Comp" System (Coulter Electronics, Hialeah. USA). 
Mean particle size was calculated by SDP analysis, 
Size distribution (ba~d on solid sphere weight re- 
suits) is given as polydispersity index (Pl) - -  varying 
from 0 (entirely monodisperse) to I (completely 
polydisperse suspension). 
2.3. Determbu+tion ~¢ celhdar uptttke 
These experiments were done acearding to D,deke 
et al. [22]. Therefore, 1 • 10" J744 mouse macrophage 
like cells were seated in a 6-well plate (Costar). The 
239 
cells ~ere incubated after adherence with HPTS lipo- 
somes diluted in RPMI medium without fetal calf 
serum to a final concentration of 1(I0 /zM for the 
indicated times at 36~C. 
Control uells were incubated with the same lipo- 
some-ntedia solution at 4°C for 30 rain to determine 
binding under conditions excluding phagocytosis. 
Fluorescence measurements of marker in low pH 
compartment of macrophages were done alter coin- 
cubalion of cells with a solution of HPTS in medium 
( 100 raM) t\~r at least 24 h. 
2..~. [. FIttorescellce inellgtlretPteltls 
After incubation the cells were harvested by scrap- 
ing off and counted. Fluorescence of HPTS of cell 
suspensions were determined using a FARRAD spec- 
trofluommeter MKI (FARRAD Optical, New York, 
USA), Excitation wavelength used was 415 and 450 
ltnl and emission wavelength was 5 I0 nnl. 
Differentiation between general uptake and phago- 
cytosed marker was done using the following equa 
lion 
, ,  - ( 1¢,,,:,~ - R .~) / (  t¢.,o~ - R,..,) 
where m: amount of HPTS in liposomes associated 
with cells, given in percent, R,,,= G fluorescence ratio 
(450:415 nm) in cells after HPTS uptake. R,,,~,: fluo- 
rescence ratio (450:415 nm) after liposome associa- 
tion tit 4°C. R~p: fluorescence ratio (450:415 nm) 
fotmd for liposomal HPTS in the experiment. 
Absolute quantification of HPTS was done using a 
standard curve, based on fluorescence at excitation 
wavclettgth 415 nm. 
The amount of associated/internalized HPC was 
calculated from the HPTS-amount after determination 
of the lipid content of each liposomal preparativu and 
was finally normalized to the uptake of 10 ~ cells. 
All experiments were done in duplicate and the 
results represent he mean of at least 4 separate 
experiments. Statistic evaluation was done using Stu- 
dent's /-test. 
2.4. FALT  determination 
Falt determination ~vus based on measurement of 
the electrophomtic mobility of liposomes in sample 
solutions prepared by appropriate dilution with iso- 
tonic solution of 10 mM lactate buffer (pH 4) with 
various concenlrations of NaCI and sucrose (for de- 
tails see tables and figures) as reported recently [25]. 
Zeta potenlial of these suspensions (calculated by 
applying the Smoluchowski equation) were deter- 
mined using the eleetrophoretic light scattering appa- 
ralus ELS 800 (Otsuka Electronics, Osaka, Japan) at 
25°C. 
The lu zeta polential ~" (V)  was plotted versus 
Dcbyc H~ckel parameler (k}. K represents 3.3(C. 
~here C i~ the conceulration of electrolytes in the 
solution. The slope of the obtained plots indicates the 
thickness of the fixed aqueous layer in nm. 
3. Results 
3.1. Ce lh&,"  uptake 
The uptake of alkylphosphocholine lipusomes will: 
regard to size. time and slerieal stabilizalinn was 
detemtined. Lipnsome~, were prepared from MLV 
(size > 1000 ore, polydispersity index about 0.65) by 
repeated extrusion thn)ugh polycarbonate filter with 
pore size of 100 nm (LUVET 100) or 400 nm 
(LUVET 400) and obtained with diameters of about 
120 +_ 10 nut (PI 0.06) and about 250_+ 15 nm (PI 
0.28) respectively (Table I). 
Starting with a 30 mM solution the amount of 
encapsulated hydrophilic fluorescence marker HPTS 
wlried and was lbund to be between 37.5 (PEG- 
LUVET Ifi0) and 157.8 pmol /nmol  HPC (PEG- 
MLV), 
The ce?ular uptake was determined based on IIPTS 
encapsuhlled in the HPC liposomes. The content was 
R. Zeivig ct al. / Bioc himk a et Bioph) s&'a Acta 128511096) 237-245 
estimated using 415 nm excitation wave length and a 
snmdard curve in the appropriate concentration range. 
The total amount of liposomes associated with cells 
(indicated as uptake and including cell membrane 
bound vesicles and lipnsomes already internalized) 
was determined in a similar way after harvesting the 
cells. The concentration of HPTS was obtained from 
the standard curve, normalized to 1 million cells and 
the amount of HPC calculated based on the amount 
of encapsulated HPTS. 
Determinations were carried out at various lime 
points of up to 18 h during which the uptake of 
l iposomes increased with time (Figs. I and 3At. Most 
liposomal HPC was associated with macrophages 
coincubated with MLV. The lowest amount of HPC 
was found at cells treated with small l iposomes (Fig. 
I). The differeace in HPC-uptake with regard to size 
was significantly different between mr~e.ro, pbage,~ co- 
incubuted with MLV and cells incubated with the 
smaller vesicles alter 6 and 18 h ( P < 0.05). 
Sterical stabilization of HPC liposomes resulted in 
a clear reduction in liposomal uptake for Fipnsames 
of all sizes by at least 47% (MLV) after 18 h of 
incubation (Fig. 2A and Fig. 3At. We already found 
differences for shorter incubation times but they were 
not significant ( P > 0.05) For example, the compari- 
son of plain and sterically stabilized liposomes is 
given for the 2 h incubation period in Fig. 2B. A 
complete data set for LUVET I00 is plotted in Fig. 
3A. 
The internalization of l iposomal HPC into the low 
pH compartment was estimated at lhe pH-dependent 
excitation wavelength 450 nm. The changes of the 
fluorescence ratio 450:415 allow the calculation of 
Table I 
CharaclclizallOn of llposonl~ used I'q~v de~ermimltion of ula¢lopha~c Lipl;ik¢ 
Lipo~l~mc~ Size tam) PI HPTS (pmol/nmol HPC)  
LUVET IUU 122.7 _+ 10.3 0,(162 ~ n tl¢l~) 41.2 _~ 22. I
PEG-I_LJVET I nn ; i :>.4 + IU,2 u,usn + u,1137 37.5 + I U.6 
LUVE'F 4(10 255.4 i I 1.4 (),265 ± a,08 84.3 _+ 3g.8 
PEG LUVET 4(10 238.4 + 17,5 11.287 ± 11.(t85 83.4 _+ 33.0 
MI.V 1917,3 + 1641 8 I1,053 _+ 11,3112 119.7 + 57,9 
PEG-MLV 1257.2 4 !()3U 8 U.6t/6 + 11,345 157.8 + 22.4 
Lipt)somes Welt pl-epttrL+d :p,de'scribed ill Set?li(~ll ~ SIze' ~x~t~, determined by photon ¢orl'ektli+ul spectroscopy using a Coulter M4 panicle 
sizcr ~]t an +ltlgle ot 9(~:. Data I'¢ptCSellt th+ mearl _+ S.D. for tout differcnl iposomal plCpali~?!Oll+ Diameh'r and xize distribtaion wcrc 
baaed oII t~HilTIOklill [Chkdt~. Cqultcnl ol HPTS xx'~ls d~'lcrllallcd by tluOI"csL:¢IWc s~.'ctrO+cOpy at 51p IlIa emission mid 415 nm excitatinn 
wav,..]cllgth~+ Con~¢I]ll~L~lOl] (a HPC was ~lbt~l~llu.lla ~)x HPTI.C.  
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Fig. I, The mnounl tit HPC (nlean + S.D., ,t ~ 3) calculated i~u 
iotal cellular uptake by J774 ct, ll> (about 5 Ill ~ cells) alter 
poincubaliun t;ith intlicaled HPTS-lipt+~omes < ItIn I~MI ft+r dill 
terenl limes as described ill SeCliOIt 2 are gi~ on. Cnllcentration ol 
HPTS wax determined ha~ed on a ~latldard cur~c h~ tltlore~cel~ce 
measurements (FIM: 513 nnl//-" I x: 415 lira). 5iignilicanl dil- 
l)rent to IIR) nm LUVET. 
the percentage of  internalized liposomes, Theretbre, 
control experiments were carried out, The tluorcs- 
eenee ratio for HPTS in l iposomes ordy associated 
with the cell membrane was obtained alter incubation 
of  cells with HFrS- l iposomes at 4°C. The fluores- 
cence ratio for HPTS in the log, pH comparmlent 
after pinocytosis was est imated after macrophage 
coineubation with molecular HPTS solutions. 
The results of internalization are similar to the data 
already tbund for the total uptake. The amount of 
l iposumes found within the macrophages were also 
directly dependent on the size uf  vesicles. PEG-l ipn- 
somes were internalized much lower than plain lipo- 
sprees of the same size. The slerically stabil izalion 
seems to binders the internalization of these vesicles 
into the cells in contrast to the binding nf  l ipusomes 
which was not delayed. Only after longer incubation 
t imes the effect of  stcrical stabil ization was over- 
come. Here the amount of  internalized HPC increased 
from control level to 75c/, ( LUVET 1001. 72% 
ILLIVET 400) and 48q, (MI+V) of that calculated l'nr 
total uptake lFig+ 3A+B). 
3.2. Zemj~otential III('(ISIIFt'nwIHS 
The thickness of  the aqueous layer around lipo- 
>ames was Lalculated l\)r 3 selected lipuxomal prcpu- 
raltiou:', to inxesligute the innuence of the sterical 
stabil ization tcomparison t,f plain HPC-LUVET and 
PEG- I IPC-LUVET)  and to compare the influence of 
the lipid used as the main "br~k + - , r  liposomul 
preparation (comparison between PEG-HPC-LUVET 
and PEG-OPP-LUVETh The liposomcs lur tllese e \ -  
periments uet~e of a average diameter o1" 1(16.8 _+ 3.g. 
127 .4+ 1.4 and 113,1 _+ 1.7 nm fur HPC+LUVET,  
PEG-HPC-LUVET and PEG-OPP-LUVET reslmC- 
tlvely with a pnlydispersity index lower than 0.08. 
The zeta-potentials esl imated for these tiposomes in 
isololtic blClale bnffer with SLEFUSt2 [Intl sodium chlo- 
rkle in eoncenttlttions between 5 and 100 mM are 
gixen ill Table 2. TIle pH of the buffer was fixed at 4 
A 
- i ,_a ,: 
i 0 l B 
--~ 8 PEG-I,~oscme~ 
8 
5 
0 LUWT tO0 LUVET aOD MLV 
Liposomal Preparation 
Flea. 2, Camp;at,on of philo illld sterlcaily stabilized HPC liD*- 
spines (PEG-lip~n~mlca) l~n hptill uplake itl~cr 18 h (A) or 2 h (B) 
of ct~in~ul}at[on Of 1774 ceils wial I(10 g~,l liptlsOllleS, Given tire 
tile COllCelllration of HPC hllt~llll+S.D., ii ~ 31 calculated as 
dc.cribcd ill ScetiOll 2 based i}n tlttole,cenee meastINiilelllS of 
tlPIS ( I- I M: > 13 nnl/I:hX: 415 nm). " Nignfficauny diftk:mnl m 
plain lip(~t)ln¢ ~
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~° i 1 : I Plain LUVET /'~ 
8 ' r - -  PEG LUVET 
6 
E- I 
o 
c~ 
~tml 0s 2 n ~, ~ 
+°i B 
§ T 
o 
0s 2 4 6 18 
Incubation time (hours) 
Fig. 3 Tolal uptake (A) and internalization (B) ~ff HPC- (plain 
LUVET) and sterically stabilized HPC-liposomex (PEG-LUVET). 
bi)lb exlrudcd through I00 nm pore site. were Ibllowed fnr 18 h. 
J774 ceils were coincubated with 100 #M of liposomes, After 
indicalcd limes the cunccnlration tlf the marker HPTS was deter- 
mined by fluorescence measurements (FEM: 513 nm/F[!x: 415 
nm, A ~nd F~M: 513 nm/F~x: 450 nm, B). Given are the 
cmtcenlraticm of FIPC (Inean+S.D.. n>_3) calculaled as de- 
scribed ill Section 2. " Significanlly diflerent o plain lipnsomes, 
.2.s 
i -4,o 
-5,0 
-5,5 
-6,0 
O.o 0.2 0,4 0,6 0,8 1,0 1.2 1+4 
kappa ( l lnm) 
Fig. 4. Electrophoretic mobility of liposomes were measured in 
isotonic solution of 10 mM lo¢late buftbr (pH 4) with various 
concentrations of NaCI and sucrose (for delails see Section 2 and 
Table 2), Natural ogarithm of the absolute value of zeta potential 
(V) was plotted versus Debye Hiickel parameter (to). 
represents 3.3,/C. where C is the coneenlmtion i  mol of elec- 
trolytes in the solution, v .  plain HPC-liposome" HPC/CH/DCP 
(10:10:2 molar ratio); ~1' . PEG-HPC-LUVET,  
HPC/CH/DCP/PEG,_~.~DSPE (10:10:2:1 molar ratio): *. 
PEG-OPP-LUVET, OPP/CH/I)CP/PEGzmmDSPE (10:!0:2:1 
molar ralio). 
to obtain similar conditions compared to previous 
pneasuremel]tS using l iposomes made from dimyris- 
toyl phcsphochol ine l iposomes with and without dox-  
orubicin [25]. The absolute value of the potential 
decreased with increasing concentratioa of salt. The 
decrease was at its smallest with plain liposomes. 
Table 2 
Dependence of zeta potential o+1 electrolyl¢ c~mcuntrali~m 
NitCl and Plain HPC-LUVET PEG-HPC-LUVET PEG-OPP-LUVET 
blCtate (mM) 
5.6 - 31.82 + 1.73 - 15.4U _+ 0.51 - 13,1b ~ 0.35 
10.6 33,86-± I,bh 20.98 + 1.62 -10,66 ~ 1.27 
15.6 40.94 + 639 14.66 +_ 2.32 9 67 + 0,55 
20.6 - 35.96 _+ 2.18 - ; 1,08 + I ,fl2 6.78 + 0.33 
50.6 -23,94+ 1.39 - 4,19+0,52 - 2.51 _+ 1.52 
100.6 21199 _+ 1.04 nd nd 
Zeta putential nleastlrcrllcnl were done ~,~Jlll [ipust+lnes composed i~f APt./CH/DCP (Ifl:llh2) or APL/CH/DCP/PEG2mM>DSPE 
( 10:10:2: l iiio~ar ratio), diluted ill i,UlOnIC htclale huff or ctmtaining dit'fierent Collcentrations of NaCl and ~ucrose. Result~ are e×pres~ed a~
means + S.D. ( ,  > 3). 
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Table 3 
Thickness of the fixed aqueous lay¢~ around APL fipos~lmes 
Liposomal preparation Thickness (nm) .4 " R" " 
Plain HPC-LUVET " 0.83_+0.17 3.I)fi 0.922 
PEG-HPC-LUVET i~ 3.57 + n. 17 2.t,7 0996 
PEG-OPP-LUVET ~ 3.44_+0.31 3.25 0.988 
PEG-DMPC-LUVET ~ 3.2 - 320 OtiS0 
FALl" results v.ere stlmaled fi'om Fig. 4. 
Liposomal composition: ;' APL/CH/DCP tlo:ia:2h 
APL/CH/DCP/PEG2nm~DSPE ( 1(1:10:2:1 ). 
¢ DMPC/CH/DMPG/PEG,,~DMG (10:t0:h:5:4 molar atio): 
data taken from Ref. [251. 
• Chata~ieristics for linear regression, based t,n Y= A ~ BX, 
(,z _> 5k 
Deviations from the exponential slope were fuund at 
a very low salt concentration, but the plot of ln[-zeta) 
against he Debye-Hiickel parameter K fits best to a 
linear function (Fig. 4). Here K represents 33  ¢c, 
where c gives the concentration of electrolytes in- 
cluding NaCI and the dissociated autount of lactate in 
the buffer system (for details see [25]). The slope of 
these plots indicates the thickness of the fixed layer 
in nm. The results are given in Table 3. Both steri- 
tal ly stabilized liposome preparation have a similar 
thickness of the aqueous layer of about 3.5 nm. The 
thickness of this layer was clearly reduced for plain 
liposomes and calculated to be only about one fourth 
of the former. 
4. Discussion 
The main problem to obtain a high efficiency of 
liposomal drugs on targets different from the RES is 
the rapid clearance from the blood circulation. The 
method mostly used to circumvent uptake by 
macrophages as the main components of the RES is 
the sterical stabilization by poly(ethylene glycol) 
derivatives of PE incorporated into the liposomal 
membrane [11-16]. 
In a previous study we could demonstrate that it is 
possible to prepare liposomes of a defined size with 
and without sterical stabilization using alkylphospho- 
cholines as liposomal and active cancerostatic lipid 
within one vesicle preparation [I,20]. 
First experiments gave indirect evidence for a 
reduced interaction of these PEG-HPC-LUVET with 
~3 
phagocytic ells [201. The activation of macrophages 
:.: ~elease cytotoxic mediators like NO or TNF in 
viuo induced by APL-liposomes [19,27] was de- 
creased to the level of control ceils if PEG-liposomes 
were used for activation. Additional data demon- 
strated that the uptake of particles like carbon ink 
was not affected in vivo by the application of PEG- 
liposomes prior to ink injection in contrast o classi- 
cal liposomes where a dramatic change of particle 
clearance was induced [20]. 
To continue in',~stigations of sterically stabilized 
liposomes prepared from alkylphospholipids, the 
study v, as directed at two aims. First, we v, anted to 
quantify the uptake of PEG HPC-liposmnes by 
maerophages in vitro. In a direct way this should 
prove whether sterical stabilization works with 
alkylphosphocholine liposomes in the same way as it 
was tbund lbr liposomes made from natural lipids. 
Secondly, we wanted to characterize the liposomes 
with regard to thickness of the fixed aqueous layer 
around the outer membraue which is made responsi- 
ble for the variation in immune response. 
Different methods have been used for the determi- 
nation of cellular liposomal uptake mostly based on 
measurements of encapsulated fluorescent [22,23,28 
30] or radioactive marker [6,8]. But uptake of lipo- 
somes is a process consisting of association of lipo- 
somes to the cellul,'u" membrane and transport of 
liposomes into the intraeellular compartment by en- 
docytosis. It is possible to differentiate between both 
liposomal quantities in a classical way by doing two 
separate xperiments, one for general uptake and the 
other for conditioo~ necesstu'y for binding without 
eodocytosis. 
Another possibility for the characterization of 
macrophage uptake allows the encapsulation of the 
fluorophore HPTS [22,31]. The amount of marker is 
determined in this simple and suitable assay using the 
pH independent excitation wavelength 415 nm for 
total uptake. The part of internalized liposomes was 
obtained from fluorescence at excitation wavelength 
450 ore, at which fluorescence is strongly dependent 
on pH. Both data sets were obtained for the same cell 
popuhuion and are highly comparable. Therefore we 
selected this assay for our experiments. 
Until now sterically stabilized liposomes only pre- 
pared fi'om natural lipids with a classical glycerol 
backbone structure were characterized with regard to 
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immune response in rive [32 35]. On Ihe other hand. 
only a lew sludies in vitro have been reported quanti- 
fying the macrophage uptake of PEG-liposomes 
[6.24.36], 
II1 our experiments we were interested in using an 
optimal iposome prepurati,,m with regard to minimal 
macrophage uptake. It was demnnstrated in all exteu- 
sire study on lipost}mal uptake in vitro that the 
amount of PEG-lipid should be between 5-10 n]ol% 
[b]. Theoretical estimation bused on calculation of the 
protective square radius of PEG lipid resulted in 1000 
molecules necessary for the complete pmteetiun by a 
polymer of molecular wcight 2000 Da [37.38]. This 
corresponds to 4.7 mol%r Therefore we prepared 
liposomes containing 4.3 mol~ PEG~I>{IIIDSPE based 
on complete molar liposomal compounds (or 10 reel% 
related to HPC), 
The data obtained in our study demonstrated that it 
is possible already in vitro to characterize the influ- 
ence of liposomal compositi,.m on interaction with 
macrophages. This is in a good agreement with data 
obtained in comparable studies using liposames pre- 
pared finm egg-PC [6,24,36]. 
The preparation of liposnmes using alkylphospho- 
cholines with their simple mono chain structure as 
main liposomal 'brick' is possible without any prob- 
lem. if tin equimolar amount of cholesterol is used 
[I,20]. We fomtd no intertErence of HPC Io propel'- 
ties of sterical stabilization. All the liposomes investi- 
gated were significantly higher bound to macrophages 
than the sterically stabilized ones. The liposomes 
were taken up by J774 n'~acrophages in a thue depen- 
dent manner. 
Another important fact+Jr infiuencix+~g the cellular 
uptake is the vesicular size. Although there is a 
generallsatinu that smaller liposomes were taken up 
utach slower fi'OlrL the blood circulation [21,39] the 
uptake iu vitrc, was Ibund to be negatively correlated 
to size [6.40]. lit (mr study uplake was f(mnd to be 
positively con'ekned to vesicular size irrespective of 
whether the liposomes were stel'ically stabilized or 
not. The highest un+tount of HPC was determined for 
coincubation with MLV with a It]earl diameter larger 
then 1 p,m, whereas the uptake of smaller lipos~nnes 
was nearly similur. 
Taking into account that tile Iransp+,)rl of vesicles 
into the cell takes aboul 3~ ~ rain [38], the intcrnaliza- 
tion was clearly inhibited up to 6 I1 fo," the PEG 
R. Zt'isi~' el ed, / Bioe hioric a et Biophysi~'a Al' la 12&~ f 199t~? 237-245 
liposomes compared to plain liposomes. Further, no 
difference was found comparing the ratio betv.,een 
total uptake and internalization of liposomal prepara- 
tions with and without sterieal stabilization after 18 h 
of eocuhure. This indicates that sterical stabilization 
is mainly influencing the binding process to the 
cellular surt;aee and only to a lesser degree the trans- 
port into the cell [10]. This agrees with the finding 
that J774 cells have higher binding sitcs and higher 
binding constants for PS /PC/CH liposomes than 
that for PC/CH liposomes, but the rate constants for 
endocytosis was similar for both lipnmme prepara- 
tions [29]. 
The mechanism(s) of sterical stabilization for pre- 
vention of cellular uptake has not yet been com- 
pletely understood. A marking by the incorporation 
of serum complements like proteins into the liposo- 
mal membrane (opsonization) seems to be an essen- 
tial process for the recognition of such particles by 
macrophages [3-5.22.39]. If this opsonization is 
missing, the liposomal uptake by macrophages i  
inhibited. 
It was demonstrated that the incorporation of pro- 
teins into the bilayer or on the liposomal membrane 
is dramatically reduced after stericnl stabilization [40]. 
There are two different explanations for this phe- 
nolnenon. First. the high hydrophilic polyethylene 
chain could form a dense conformational c oud over 
the outer liposomal surface resulting in a physical 
sterical barrier which inhibits the interactions of lipo- 
snmal components with molecules in the solution or 
prevents the incorporation of proteins [37]. Secondly, 
the hydrophilic chain results in a formation or in- 
crease of u fixed aqueous layer around the outer 
liposomul surface, which should complicate the op- 
sonization by proteins from serum. 
In onr understanding there is no real discrepancy 
between both explanations. It is likely that the hy- 
drophilic hain of the PEG lipids form a steric barrier 
but with a very dynamic character [37]. This should 
allow the incorporation of water molecules between 
the polyethylene chains and thus the forming of the 
fixed aqueous layer just around the liposomal bilayer. 
Both could explain the prevention of charge to charge 
iltteraction between liposnmal membrane and pro- 
reins. 
Our resuhs delnonstntte thai even sterically stabi- 
lized liposomes made /Yore nausual ipids show simi- 
R. Zeisig et aL / Bit~chimica cr Hi~,i~h) xit a 4~ t¢~ l 2s5  ~ ! #tl6* 237 24  ~ 
lar protect ion t~r mucrophage uptake, wh ich  could be 
further  enhanced by the careful selecl ion of  l iposomal 
size. 
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